Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women. - Early Breast Cancer Trialists' Collaborative Group,(.EBCTCG). (Lancet, 1992)